| 
A machine learning-based approach for the inference of immunotherapy biomarker status in lung adenocarcinoma from hematoxylin and eosin (H&E) histopathology images.  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Bristol-Myers Squibb; Verily  | 
Patents, Royalties, Other Intellectual Property - Celverum; Verily  | 
Travel, Accommodations, Expenses - Verily  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Verily  | 
Patents, Royalties, Other Intellectual Property - Verily  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Google  | 
Research Funding - Google  | 
Patents, Royalties, Other Intellectual Property - Google  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Verily  | 
Travel, Accommodations, Expenses - Verily  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Verily  | 
|   | 
 | 
Employment - Agilent; Premier Pathology Laboratories, Inc.; Verily  | 
Leadership - Premier Pathology Laboratories, Inc.  | 
Stock and Other Ownership Interests  - Agilent; Premier Pathology Laboratories, Inc.  | 
Travel, Accommodations, Expenses - Merck  | 
|   | 
 | 
 | 
Stock and Other Ownership Interests  - Verily  |